Objectives: No specific treatment has been approved for COVID-19. Lopinavir/ritonavir (LPV/r) and hydroxychloroquine (HCQ) have been used with poor results, and a trial showed advantages of combined a

NIAID Data Ecosystem30

The baseline resistance-associated substitutions (RASs) and virologic failure in patients treated with sofosbuvir and ledipasvir.

病毒药物疗效

病毒耐药性分析

The baseline resistance-associated substitutions (RASs) and virologic failure in patients treated with sofosbuvir and ledipasvir.

Figshare2018-06-01 更新20

Mini data set of children enrolled on protease inhibitor treatment as Essos Hospital Centre.

儿童HIV治疗

病毒药物疗效

ART: antiretroviral therapy, NNRTI: non-nucleoside reverse transcriptase inhibitor; PI/r: ritonavir boosted protease inhibitor;. (XLS)

NIAID Data Ecosystem30

Favipiravir and zanamivir clear influenza B infection in an immunocompromised child

病毒药物疗效

流感B感染

Data associated with a long-term influenza B infection in an immunocompromised child. These data replace the earlier submission PRJNA545892, reflecting an update in our pipeline for removing human seq

NIAID Data Ecosystem30

Measures of the impact of NAI treatment under various conditions <sup>*</sup>.

资源简介：

相关数据集